Axsome Therapeutics (AXSM) Price/FCF Ratio: History & Chart

Axsome Therapeutics, Inc.(AXSM)

Biotechnology · New York City, NY

$174.70-2.38 (-1.34%)

Delayed quote: Oct 6, 2026, 11:35 AM EDT

About Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) disorders within the United States. Its robust product pipeline features several promising candidates, including: AXS-05, an investigational therapy currently being developed for major depressive disorder and treatment-resistant depression. This compound is also in Phase III clinical evaluation for Alzheimer's disease agitation and has successfully finished Phase II trials investigating its use for smoking cessation. AXS-07, a novel, orally administered, rapidly-acting investigational medicine that employs multiple mechanisms of action. It has concluded two Phase III studies for the acute treatment of migraine attacks. AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is presently undergoing a Phase III trial for narcolepsy. AXS-14, an oral investigational drug, advancing through Phase III trials for the management of fibromyalgia. Axsome Therapeutics also engages in a research collaboration with Duke University to further assess AXS-05's potential in smoking cessation. The company, established in 2012, has its main offices in New York, New York.

New York City, NY

1,346 employees

www.axsome.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Herriot Tabuteau

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Axsome Therapeutics, Inc. (AXSM)	$8.99B	N/A	N/A	N/A	N/A
Bruker Corporation (BRKRP)vs ›	$8.98B	95.63	1012.95	992.25	992.25
Protagonist Therapeutics, Inc. (PTGX)vs ›	$9.01B	69.02	96.70	52.90	52.90
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.80B	N/A	106.69	106.69	68.15
Bruker Corporation (BRKR)vs ›	$9.30B	99.00	132.35	74.15	69.02
Kymera Therapeutics, Inc. (KYMR)vs ›	$8.73B	N/A	34.88	34.77	34.77
Insulet Corp. (PODD)vs ›	$9.40B	31.50	39.52	71.17	71.17
Oscar Health, Inc. (OSCR)vs ›	$8.44B	1.95	3.94	6.21	7.86
Vaxcyte, Inc. (PCVX)vs ›	$9.69B	N/A	N/A	N/A	N/A
Henry Schein, Inc. (HSIC)vs ›	$9.74B	18.08	20.79	20.36	19.71

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Axsome Therapeutics, Inc. (AXSM)

$8.99B

N/A

Bruker Corporation (BRKRP)vs ›

$8.98B

95.63

1012.95

992.25